Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma

Clinical trial NCT07059611 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07059611
Sponsor: Abramson Cancer Center at Penn Medicine
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Gastric Adenocarcinoma Esophageal Adenocarcinoma Gastroesophageal Junction Adenocarcinoma

Start date: 2026-09-01
Primary completion: 2027-11-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.